106 related articles for article (PubMed ID: 2195734)
1. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
[TBL] [Abstract][Full Text] [Related]
2. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
[TBL] [Abstract][Full Text] [Related]
3. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials of cyclosporin in IDDM.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
[TBL] [Abstract][Full Text] [Related]
5. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
[TBL] [Abstract][Full Text] [Related]
6. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
9. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and aetiological classification of insulin-dependent diabetes in the elderly.
Kilvert A; Fitzgerald MG; Wright AD; Nattrass M
Q J Med; 1986 Sep; 60(233):865-72. PubMed ID: 3306756
[TBL] [Abstract][Full Text] [Related]
11. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
Krarup T; Madsbad S
Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
[TBL] [Abstract][Full Text] [Related]
12. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
[TBL] [Abstract][Full Text] [Related]
14. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.
Boitard C; Feutren G; Castano L; Debray-Sachs M; Assan R; Hors J; Bach JF
J Clin Invest; 1987 Dec; 80(6):1607-12. PubMed ID: 3316278
[TBL] [Abstract][Full Text] [Related]
17. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.
Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
Diabet Med; 2004 May; 21(5):447-55. PubMed ID: 15089789
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
Schories M; Peters T; Rasenack J; Reincke M
Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
[TBL] [Abstract][Full Text] [Related]
19. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
